Rain Therapeutics (RAIN) has released an update to notify the public and investors about a material modification to rights of security holders.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The current report consolidates details from several sections, including completed corporate events, changes to rights of security holders, director and executive officer changes, and amendments to the company’s code of ethics and bylaws, into a singular section for streamlined reference.
For further insights into RAIN stock, check out TipRanks’ Stock Analysis page.